J Allergy Clin Immunol May 2014 PMID 24766875

The diagnosis and management of acute and chronic urticaria: 2014 update.

Jonathan A Bernstein, David M Lang, David A Khan, Timothy Craig, David Dreyfus, Fred Hsieh, Javed Sheikh, David Weldon, Bruce Zuraw, David I Bernstein, Joann Blessing-Moore, Linda Cox, Richard A Nicklas, John Oppenheimer, Jay M Portnoy

Mentions

9
Peak: 1 in Jan 2023
across 4 sources since Jan 2023

Extended reach

32
potential audience

Total likes

6

Video views

27

Mentions per month

Jan 2023 – Jul 2025

Where it's discussed

  • Facebook4 posts
  • News3 articles
  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

Many users praise the comprehensive nature of the guidelines, with some expressing agreement on the tailored approach to individual patients. Others actively dissect specific sections, such as the emphasis on testing and management strategies, reflecting their invested interest and perceived clinical impact. The tone varies from supportive to inquisitive, showing a deep engagement with the material.

AgreementModerate agreement

Most discussions acknowledge and support the guidelines, emphasizing their importance and relevance.

InterestHigh interest

The discussions demonstrate high interest, with users actively engaging with the content and highlighting its clinical significance.

EngagementModerate engagement

Participants are sharing detailed insights, asking questions, and referencing specific parts of the publication, indicating moderate to deep engagement.

ImpactModerate impact

The discussions suggest that the publication influences clinical practice and debates, especially on treatment and diagnostic approaches.

Abstract in brief

  • This document, developed by a joint task force representing major allergy and immunology organizations, provides comprehensive guidelines for diagnosing and managing both acute and chronic urticaria, emphasizing that recommendations should be tailored to individual patients due to the evolving medical environment.
  • It highlights that no single person or organization can interpret these guidelines definitively, and any such requests should be directed to the official offices of the AAAAI, ACAAI, or the Joint Council.
  • The guidelines acknowledge the importance of testing and treatment costs but generally do not factor them into recommendations due to variability and limited economic data, except in cases where cost-benefit considerations are supported by specific pharmacoeconomic research.]

Top posts

Most liked on X and Bluesky
Erika Tsutsui
@ErikaTsutsui · X

The diagnosis and management of acute and chronic urticaria: 2014 update https://t.co/kNXAiCjLsC

Jan 11, 2023 · 5 followers View post →

All mentions

Erika Tsutsui
@ErikaTsutsui · X

The diagnosis and management of acute and chronic urticaria: 2014 update https://t.co/kNXAiCjLsC

Jan 11, 2023 · 5 followers View post →